Target intelligence / Profile preview

RNA, U6 small nuclear 1022, pseudogene (RNU6-1022P)

Target
RNU6-1022P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 1022, pseudogene (RNU6-1022P) is a processed pseudogene of the U6 small nuclear RNA (snRNA) in the human genome[2][4][5]. U6 snRNA itself is a non-coding RNA component of the spliceosome involved in pre-mRNA splicing[1][3], but the pseudogene copy (RNU6-1022P) does not encode functional RNA and is not involved in biological processes or disease, nor is it a direct therapeutic target[2][4][5]. U6 snRNA pseudogenes such as RNU6-1022P are typically formed via retrotransposition (often LINE/L1-mediated), serve as evolutionary markers of genome dynamics, and generally lack known biological function, therapeutic relevance, or drug interactions[4]. The presence of "pseudogene" in the full name and lack of an associated protein or functional RNA makes this distinct from canonical molecular targets, meaning this entry is not a valid therapeutic target and should be labeled as biologically inactive (incorrect as a drug target)[2][4][5].

Other names
RNU6-1022PRNA, U6 small nuclear 1022, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1022, pseudogene (RNU6-1022P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1022, pseudogene (RNU6-1022P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call